Ukraine: 3 WHO humanitarian warehouses destroyed in 3 months - World Health Organization (WHO)

Editor's Note: This is a developing story and is being updated. Ukrainian forces appeared to strike multiple targets across Russia's Moscow, Rostov, and Vladimir regions in a widespread drone attack overnight on Oct. 16. The Kyiv Independent can not independently verify attack targets or damage at this time. According to monitoring channels ExileNova+ and SuperNova+, Russian technology giant Yandex's data center in Vladimir Oblast, around 500 kilometers (310 miles) from the Ukrainian border, was targeted in the overnight operation. Footage from residents at the scene shows large explosions and air defense systems operating around residential buildings. Following strikes on the same Yandex site on Oct. 11, the company announced operations at the data center had been completely shut down. That strike marked the third near-consecutive day of attacks on Yandex data centers in Russia, following confirmed strikes in Ryazan and Kaluga oblasts on Oct. 8 and 9. The string of attacks on Russian data centers follows President Volodymyr Zelensky's statement that Ukraine would retaliate in kind to Russian strikes on Ukrainian internet infrastructure.

Bioengineer.org news storyFor people living with HIV, modern antiretroviral therapy can suppress the virus to levels below what standard laboratory tests can detect. Yet some patients on long-term treatment experience a curious phenomenon: a single test result showing a small, transient amount of virus in the blood, followed by an immediate return to undetectable levels. These events, known as viral blips, have puzzled clinicians and researchers for years, raising questions about whether they represent harmless statistical noise, brief bursts of viral production from hidden reservoirs, or early warnings of impending treatment failure. A new nationwide Swedish study, published in BMC Infectious Diseases, offers one of the most comprehensive answers to date. Drawing on the Swedish national InfCareHIV cohort, researchers analyzed data from 4,210 treatment-naïve adults who began antiretroviral therapy from 1 January 2007 onward, with follow-up data extracted through 30 September 2020. The median observation time was 5.5 years, with some individuals followed for as long as 13.7 years.